Member Info for itsallamess

https://twitter.com/SEACoronavirus/status/1252108435497406467?s=19

Malaysia will now trial interferon b along with the bitter hitter flop drugs!

Anti viral drug Remdesiver
HIV drug Lopinavir/ritonavir

Might as well add steroids as well

Traumakine will be the last man standing

COVID-19 cure hopes dashed as trial finds HIV drug has little effect https://mol.im/a/8253157 via http://dailym.ai/android

FTSE drops again as it slumps due to gloomy prospects for new drugs https://mol.im/a/8252633 via http://dailym.ai/android

https://www.icnarc.org/Our-Research/Studies/Remap-Cap/Information-For-Sites/Site-Recruitment

UK sites

https://www.icnarc.org/Our-Research/Studies/Remap-Cap/About

Up to 269 paitents with 149 in the UK

Now the dust has settled from the placing.

We now have another 14 million euros plus the Broker shares possibly another 2 millionish

Only way to buy now is on the open market and grabbing shares from the free float which on AIM is even smaller as for the past 6 month the Fins have been syphoning off for the NAZ

MMs probably have orders to fill now... Hold on to your shares!

https://www.utu.fi/en/people/maija-hollmen

This is Marku and Sirpa Jalkanen daughter also working on clevegen

Sax

Can you figure this out?

https://jcs.biologists.org/content/early/2020/04/16/jcs.241463

Published article by Sirpa Jalkanen

"The Company is in the process of filing for Breakthrough Therapy status with the FDA and Prime Therapy status with the European Medicines Agency, which if granted, could provide an expedited development and review path"

Looking at some of the very large trades yesteday some over 100k I would say that alot of the broker option shares were sold

As for a RNS... is it needed?

AIM was the only market to buy FARN, then last year the company floated on the NAZ

They used half of the allotted nearly 8 million shares to attract new Finish investors
Then they used the other half yesterday... the vast majority going to Finish investors.
Add that to the existing Finnish investors. Ie the BOD, timo, Tim and all the Finish IIs

Now consider how small the AIM market is now especially as the NAZ has been buying AIM stock to sell to the FINS

The point: when we saw the NAZ sp shoot up to 12 euros the reason was heavy demand an d few shares!
The market with fewer shares is quickly becoming AIM...

Question: could the freefoat in AIM become so small swings to £12 become possible?

Joly

You use the word 'perhaps!'

have done extensive research in faron pharmaceuticals?

Lewis

It's ossible because its on the AIM market and AIM are experts in shenanigans!

*20 million cash
*Funded for the next 12 months clevegen phase 2 trials
*In partnership talk for clevegen
*Traumakine FDA approval phase 3 trials
*TRAUMAKINE REMAP-CAP trail
*partnership discussions to take it through to market

What a sold share to be in right now

Expect us to rise to new highs from here

In fact all the trades this morning at 364/365 are buys

Question is why do they want you to think people are selling when clearly the stock is being mopped up?

Still the MMs are trying to fool people

The last 20k trade down as a sell but the price 365 is clearly a buy

Last interview

https://youtu.be/4jqShDK15vI

https://www.faron.com/pipeline

http://www.panmure.com/successful-healthcare-fundraising/

Would be good to see some TR1s declared

But if I remember right from the last placing the nordic investors never declared, which could mean they were below the 3% freehold.

But the RNS today states that some new and existing IIs have bought in... we could see someone declare over the next couple of days?

The proposed Fundraise is being carried out within the authorisation granted to the Board by shareholders at the Company's Extraordinary General Meeting held on 25 October 2019 to issue up to a total of 7,871,000 ordinary shares in the Company in a directed share issue and in deviation from the shareholders' pre-emptive rights. The remaining outstanding authority allows the Company to issue up to a maximum of 3,935,500 new Ordinary Shares pursuant to the Fundraise, which represents 9.1 per cent. of all the issued shares and votes in the Company immediately prior to the Fundraise.